Magnetic Nanoplatform With Novel Potential for the Treatment of Bone Pathologies: Drug Loading and Biocompatibility on Blood and Bone Cells
暂无分享,去创建一个
[1] Adnan Memic,et al. Magnetic Nanoparticles in Cancer Therapy and Diagnosis , 2020, Advanced healthcare materials.
[2] S. Davaran,et al. Glutathione (GSH) Peptide Conjugated Magnetic Nanoparticles As Blood–Brain Barrier Shuttle for MRI-Monitored Brain Delivery of Paclitaxel , 2019, ACS Biomaterials Science & Engineering.
[3] C. Barbas,et al. Metabolomics reveals citric acid secretion in mechanically–stimulated osteocytes is inhibited by high glucose , 2019, Scientific Reports.
[4] M. G. Montiel Schneider,et al. Stimuli-responsive nanotheranostics intended for oncological diseases: in vitro evaluation of their target, diagnostic and drug release capabilities , 2019, New Journal of Chemistry.
[5] Seyed Mohammadali Dadfar,et al. Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications , 2019, Advanced drug delivery reviews.
[6] H. Thu,et al. Synergistic effects of combined therapy of curcumin and Fructus Ligustri Lucidi for treatment of osteoporosis: cellular and molecular evidence of enhanced bone formation. , 2019, Journal of integrative medicine.
[7] Mohammad Reza Hafezi Ahmadi,et al. Effects of Curcumin on Bone Loss and Biochemical Markers of Bone Turnover in Patients with Spinal Cord Injury. , 2018, World neurosurgery.
[8] Yanlin Wang,et al. Methylene blue relieves the development of osteoarthritis by upregulating lncRNA MEG3 , 2018, Experimental and therapeutic medicine.
[9] S. A. Khonsary. Guyton and Hall: Textbook of Medical Physiology , 2017, Surgical Neurology International.
[10] H. K. Manjili,et al. Preparation and Characterization of PEGylated Iron Oxide-Gold Nanoparticles for Delivery of Sulforaphane and Curcumin , 2017, Drug Research.
[11] S. Ismadji,et al. Biocompatibility and drug release behavior of curcumin conjugated gold nanoparticles from aminosilane-functionalized electrospun poly(N-vinyl-2-pyrrolidone) fibers. , 2017, International journal of pharmaceutics.
[12] V. Lassalle,et al. Simple and novel strategies to achieve shape and size control of magnetite nanoparticles intended for biomedical applications , 2016 .
[13] R. Rohanizadeh,et al. Therapeutic actions of curcumin in bone disorders. , 2016, BoneKEy reports.
[14] Jun Yang,et al. Investigation on the uptake and release ability of β-cyclodextrin functionalized Fe3O4 magnetic nanoparticles by methylene blue , 2016 .
[15] S. Baboota,et al. Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis , 2015, Drug delivery.
[16] Wei Lv,et al. Effect of hydroxyl group of carboxylic acids on the adsorption of Acid Red G and Methylene Blue on TiO2 , 2015 .
[17] B. Aggarwal,et al. The Multifaceted Role of Curcumin in Cancer Prevention and Treatment , 2015, Molecules.
[18] A. Šutka,et al. Study of the Structural Phase Transformation of Iron Oxide Nanoparticles from an Fe2+ Ion Source by Precipitation under Various Synthesis Parameters and Temperatures , 2015 .
[19] Mariana Castro-Piñol. Caracterización de la fragilidad osmótica de eritrocitos humanos en la anemia drepanocítica Characterization of osmotic fragility of human erythrocytes in chronic haemolytic anemia , 2015 .
[20] K. Priyadarsini. The Chemistry of Curcumin: From Extraction to Therapeutic Agent , 2014, Molecules.
[21] A. Shehzad,et al. Curcumin in inflammatory diseases , 2013, BioFactors.
[22] M. L. Ferreira,et al. Preparation of iron oxide nanoparticles stabilized with biomolecules: experimental and mechanistic issues. , 2013, Acta biomaterialia.
[23] B. Hameed,et al. Amino modified mesostructured silica nanoparticles for efficient adsorption of methylene blue. , 2012, Journal of colloid and interface science.
[24] O. Abdallah,et al. Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisal , 2012, International journal of nanomedicine.
[25] M. Thambidurai,et al. FORMULATION AND EVALUATION OF CURCUMIN LOADED MAGNETIC NANOPARTICLES FOR CANCER THERAPY , 2012 .
[26] B. Aggarwal,et al. Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials , 2012, The AAPS Journal.
[27] André L. Cazetta,et al. Adsorption of methylene blue on activated carbon produced from flamboyant pods (Delonix regia): Study of adsorption isotherms and kinetic models , 2011 .
[28] K. Schmidt-Rohr,et al. Strongly bound citrate stabilizes the apatite nanocrystals in bone , 2010, Proceedings of the National Academy of Sciences.
[29] A. Dinda,et al. Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress , 2010, International journal of nanomedicine.
[30] S. Rudenko. Erythrocyte morphological states, phases, transitions and trajectories. , 2010, Biochimica et biophysica acta.
[31] E. Tombácz,et al. Surface charging, polyanionic coating and colloid stability of magnetite nanoparticles , 2009 .
[32] Dongyuan Zhao,et al. Highly water-dispersible biocompatible magnetite particles with low cytotoxicity stabilized by citrate groups. , 2009, Angewandte Chemie.
[33] Guillermo Repetto,et al. Neutral red uptake assay for the estimation of cell viability/cytotoxicity , 2008, Nature Protocols.
[34] Robert A Newman,et al. Bioavailability of curcumin: problems and promises. , 2007, Molecular pharmaceutics.
[35] M. Bogataj,et al. HPLC analysis of raloxifene hydrochloride and its application to drug quality control studies. , 2005, Pharmacological research.
[36] A. Agarwal,et al. "Lumen digestion" technique for isolation of aortic endothelial cells from heme oxygenase-1 knockout mice. , 2004, BioTechniques.
[37] K. Li,et al. Spectroscopic study on the interaction between methylene blue and chondroitin 4-sulfate and its analytical application. , 2004, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.
[38] Carine Michiels,et al. Endothelial cell functions , 2003, Journal of cellular physiology.
[39] Z. Bikádi,et al. Unique, pH-dependent biphasic band shape of the visible circular dichroism of curcumin-serum albumin complex. , 2003, Biochemical and biophysical research communications.
[40] R. Meyerhoff,et al. Environmental fate and chemistry of raloxifene hydrochloride , 2002, Environmental toxicology and chemistry.
[41] V. C. Yang,et al. Identification and expression of scavenger receptor SR-BI in endothelial cells and smooth muscle cells of rat aorta in vitro and in vivo. , 2002, Atherosclerosis.
[42] P. Huang,et al. Atomic Force Microscopy and Surface Characteristics of Iron Oxides Formed in Citrate Solutions , 1999 .
[43] R. D. Beaty,et al. Concepts , Instrumentation and Techniques in Atomic Absorption Spectrophotometry , 1997 .
[44] Fu-Tai A. Chen,et al. Acid‐catalyzed reductive amination of aldoses with 8‐aminopyrene‐1,3,6‐trisulfonate , 1996, Electrophoresis.
[45] E. Borenfreund,et al. A simple quantitative procedure using monolayer cultures for cytotoxicity assays (HTD/NR-90) , 1985 .
[46] T. Mosmann. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.
[47] T. Swallen. ERYTHROCYTE OSMOTIC FRAGILITY TEST. , 1964, Postgraduate medicine.
[48] A. Westergren. Diagnostic tests: the erythrocyte sedimentation rate range and limitations of the technique. , 1957, Triangle; the Sandoz journal of medical science.